Abpro Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
Abpro is a public biotechnology company headquartered in Woburn, Massachusetts, pursuing antibody-based therapeutics for immuno-oncology and ophthalmology. It operates by deploying internal platform concepts to create multispecific antibody candidates and to advance a developing pipeline in collaboration with global pharmaceutical and research partners. The company participates in the biotechnology research sector and trades on Nasdaq under the ticker ABP. Abpro serves pharmaceutical and research organizations seeking next-generation cancer therapies, supporting collaborations that move candidates toward clinical development. Its lead program, ABP-102/CT-P72, is a HER2 × CD3 T-cell engager being developed with Celltrion, and its IND clearance enables the start of a first clinical trial in solid-tumor indications.